应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06990 科伦博泰生物-B
休市中 05-17 16:08:17
170.700
-2.100
-1.22%
最高
174.800
最低
165.000
成交量
33.46万
今开
170.000
昨收
172.800
日振幅
5.67%
总市值
374.17亿
流通市值
216.15亿
总股本
2.19亿
成交额
5,742万
换手率
0.26%
流通股本
1.27亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科伦博泰生物-B(06990): 发行364.86万股新股
和讯网 · 05-17 20:00
科伦博泰生物-B(06990): 发行364.86万股新股
科伦博泰生物-B(06990)5月16日发行364.86万股
智通财经 · 05-17 19:11
科伦博泰生物-B(06990)5月16日发行364.86万股
科伦博泰生物-B(06990)完成配售合共364.86万股 净筹约5.41亿港元
智通财经 · 05-16
科伦博泰生物-B(06990)完成配售合共364.86万股 净筹约5.41亿港元
科伦博泰生物-B05月16日主力资金流出56万元 连续3日减仓
自选股智能写手 · 05-16
科伦博泰生物-B05月16日主力资金流出56万元 连续3日减仓
科伦博泰生物-B(06990)下跌5.07%,报166.8元/股
金融界 · 05-16
科伦博泰生物-B(06990)下跌5.07%,报166.8元/股
医药行业第二次年度盛会临近,关注创新药研发进展
金融界 · 05-16
医药行业第二次年度盛会临近,关注创新药研发进展
科伦药业刘革新:科伦已上岸
经济观察报 · 05-15
科伦药业刘革新:科伦已上岸
科伦博泰生物-B(06990)股价下跌8.889%,现价港币$172.2
阿斯达克财经 · 05-13
科伦博泰生物-B(06990)股价下跌8.889%,现价港币$172.2
科伦博泰生物-B(06990)下跌5.61%,报178.4元/股
金融界 · 05-13
科伦博泰生物-B(06990)下跌5.61%,报178.4元/股
港股异动 | 科伦博泰生物-B(06990)再涨超8%创新高 公司拟融资12亿 此前主要产品获FDA批准II期试验
智通财经 · 05-10
港股异动 | 科伦博泰生物-B(06990)再涨超8%创新高 公司拟融资12亿 此前主要产品获FDA批准II期试验
科伦博泰生物-B(06990)上涨5.01%,报186.4元/股
金融界 · 05-10
科伦博泰生物-B(06990)上涨5.01%,报186.4元/股
科伦博泰生物-B05月09日主力资金流入533万元 连续3日加仓
自选股智能写手 · 05-09
科伦博泰生物-B05月09日主力资金流入533万元 连续3日加仓
港股异动 | 科伦博泰生物-B(06990)再涨超7% 公司拟再融资12亿 控股股东认购其中近7亿
智通财经 · 05-09
港股异动 | 科伦博泰生物-B(06990)再涨超7% 公司拟再融资12亿 控股股东认购其中近7亿
科伦博泰生物-B上榜05月08日主力资金加仓幅度前10个股(附名单)
自选股智能写手 · 05-08
科伦博泰生物-B上榜05月08日主力资金加仓幅度前10个股(附名单)
港股异动 | 科伦博泰生物-B(06990)现跌超4% 折价配股净筹超12亿港元 控股股东认购其中近7亿
智通财经 · 05-08
港股异动 | 科伦博泰生物-B(06990)现跌超4% 折价配股净筹超12亿港元 控股股东认购其中近7亿
【港股通】科伦博泰生物-B(06990)折让6.83%配股 净筹逾12亿港元
金吾财讯 · 05-08
【港股通】科伦博泰生物-B(06990)折让6.83%配股 净筹逾12亿港元
科伦博泰生物-B(06990.HK)折让6.8%配股 净筹逾12亿元
阿斯达克财经 · 05-08
科伦博泰生物-B(06990.HK)折让6.8%配股 净筹逾12亿元
科伦博泰生物-B(06990)拟配售364.86万股配售股份及发行合共442.39万股认购股份
智通财经网 · 05-08
科伦博泰生物-B(06990)拟配售364.86万股配售股份及发行合共442.39万股认购股份
科伦博泰生物-B(06990.HK)拟配售364.86万股配售股份及发行442.387万股认购股份
格隆汇资讯 · 05-08
科伦博泰生物-B(06990.HK)拟配售364.86万股配售股份及发行442.387万股认购股份
科伦博泰生物-B一度涨超11%创新高 主要产品获FDA批准2期试验
格隆汇 · 05-06
科伦博泰生物-B一度涨超11%创新高 主要产品获FDA批准2期试验
加载更多
公司概况
公司名称:
科伦博泰生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。该公司主要从事生物药品、化学药品原料、化学药品制剂的研发、生产和销售。该公司的产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。
发行价格:
--
{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":170.7,"timestamp":1715933297036,"preClose":172.8,"halted":0,"volume":334646,"delay":0,"floatShares":126624405,"shares":219195499,"eps":-3.068334,"marketStatus":"休市中","marketStatusCode":7,"change":-2.1,"latestTime":"05-17 16:08:17","open":170,"high":174.8,"low":165,"amount":57416034,"amplitude":0.056713,"askPrice":170.7,"askSize":800,"bidPrice":170.2,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.0683341742482173,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"listingDate":1689004800000,"adjPreClose":172.8,"openAndCloseTimeList":[[1715909400000,1715918400000],[1715922000000,1715932800000]],"volumeRatio":0.6914519281254552,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990/","defaultTab":"news","newsList":[{"id":"2436914182","title":"科伦博泰生物-B(06990): 发行364.86万股新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2436914182","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2436914182?lang=zh_cn&edition=full","pubTime":"2024-05-17 20:00","pubTimestamp":1715947245,"startTime":"0","endTime":"0","summary":"快讯正文2024年5月16日,科伦博泰生物-B宣布,公司根据配售协议成功增发364.86万股,此举或将对公司股价产生重要影响。科伦博泰生物-B在资本市场的表现一直备受瞩目,此次增发无疑为公司的长期发展注入了新的活力。对投资者而言,科伦博泰生物-B的股价波动或将成为近期关注的焦点。科伦博泰生物-B的未来发展值得期待,投资者应密切关注公司的财务报告和市场动态,以把握最佳投资时机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405172138168774a1cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405172138168774a1cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436997047","title":"科伦博泰生物-B(06990)5月16日发行364.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2436997047","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2436997047?lang=zh_cn&edition=full","pubTime":"2024-05-17 19:11","pubTimestamp":1715944293,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,于2024年5月16日根据配售协议发行364.86万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122749.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435629767","title":"科伦博泰生物-B(06990)完成配售合共364.86万股 净筹约5.41亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435629767","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435629767?lang=zh_cn&edition=full","pubTime":"2024-05-16 16:59","pubTimestamp":1715849973,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科伦博泰生物-B(06990)发布公告,配售事项的所有条件均已达成,且配售事项已于2024年5月16日完成。合共364.86万股配售股份已由配售代理根据配售协议的条款及条件,以每股股份150.00港元的配售价成功向不少于六名承配人配售。公告称,配售事项所得款项净额约为5.41亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122020.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435462683","title":"科伦博泰生物-B05月16日主力资金流出56万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2435462683","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435462683?lang=zh_cn&edition=full","pubTime":"2024-05-16 16:17","pubTimestamp":1715847433,"startTime":"0","endTime":"0","summary":"05月16日, 科伦博泰生物-B股价跌1.65%,报收172.80元,成交金额1.04亿元,换手率0.48%,振幅7.46%,量比0.86。科伦博泰生物-B今日主力资金净流出56万元,连续3日净流出,上一交易日主力净流出414万元,今日环比减少86.47%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为4.06%。该股近5个交易日上涨6.00%,主力资金累计净流入586万元;近20日主力资金累计净流入9382万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161618358b0e2687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161618358b0e2687&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435611121","title":"科伦博泰生物-B(06990)下跌5.07%,报166.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435611121","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435611121?lang=zh_cn&edition=full","pubTime":"2024-05-16 10:31","pubTimestamp":1715826670,"startTime":"0","endTime":"0","summary":"5月16日,科伦博泰生物-B(06990)盘中下跌5.07%,截至10:31,报166.8元/股,成交4842.15万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司,主要致力于内部开发差异化的治疗方法,以支持提高现有的医疗健康水平。公司已建立涵盖全部主要药物开发功能的一体化能力,能够战略性地快速推进33款差异化且具有临床价值的资产管线,其中14款处于临床阶段,并已签署了九项对外许可协议,前期及里程碑付款合共高达118亿美元。截至2023年年报,科伦博泰生物-B营业总收入15.4亿元、净利润-5.74亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/16103140665083.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435188726","title":"医药行业第二次年度盛会临近,关注创新药研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2435188726","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435188726?lang=zh_cn&edition=full","pubTime":"2024-05-16 08:56","pubTimestamp":1715820985,"startTime":"0","endTime":"0","summary":"ASCO年会将于5月31日至6月4日在芝加哥召开,此前于4月上旬召开的AACR也吸引了诸多国内知名药企、院校参与,公布的众多重磅临床数据带动医药行业关注度回升。国信证券提到,ASCO会议是每年临床数据展示的重要国际会议之一,近几年国内药企在该会议上的数据读出逐年增加,体现出国内药企的药物研发能力日渐增强。浙商证券提到,今年ASCO中国本土创新药企业多项数据入选口头摘要,快速口头摘要,临床科学研讨会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516085742876e36e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240516085742876e36e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435192659","title":"科伦药业刘革新:科伦已上岸","url":"https://stock-news.laohu8.com/highlight/detail?id=2435192659","media":"经济观察报","top":-1,"share":"https://www.laohu8.com/m/news/2435192659?lang=zh_cn&edition=full","pubTime":"2024-05-15 22:49","pubTimestamp":1715784580,"startTime":"0","endTime":"0","summary":"经济观察网 记者 张铃 “科伦现在已经上岸了。”在科伦药业(002422.SZ)5月14日发布的一份投资者关系活动记录表中,科伦药业董事长刘革新在被问及如何看待当前行业的低迷时说,行业的低迷不等于企业的低迷。科伦药业2023年业绩报告显示,其营收为215亿元,同比增长13%;净利润25亿元,同比增长44%。这是科伦药业自2019年之...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OpT5VekNIKqgZBRYeUZf5-RX6h9URb-0n6k7u3IDxet2MAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OpT5VekNIKqgZBRYeUZf5-RX6h9URb-0n6k7u3IDxet2MAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240515A0ANGR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240515A0ANGR00","is_publish_highlight":false,"gpt_icon":0},{"id":"2435134810","title":"科伦博泰生物-B(06990)股价下跌8.889%,现价港币$172.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2435134810","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2435134810?lang=zh_cn&edition=full","pubTime":"2024-05-13 15:30","pubTimestamp":1715585400,"startTime":"0","endTime":"0","summary":"[下跌股]科伦博泰生物-B(06990) 股价在下午03:30比前收市价下跌8.889%,现股价为港币$172.2。至目前为止,今日最高价为$189.2,而最低价为$172.2。总成交量为41.448万股,总成交金额为港币$7.483千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2405131829/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2435939867","title":"科伦博泰生物-B(06990)下跌5.61%,报178.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435939867","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2435939867?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:34","pubTimestamp":1715564089,"startTime":"0","endTime":"0","summary":"5月13日,科伦博泰生物-B(06990)盘中下跌5.61%,截至09:34,报178.4元/股,成交239.83万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司,主要致力于内部开发差异化的治疗方法,以支持提高现有的医疗健康水平。公司已建立涵盖全部主要药物开发功能的一体化能力,能够战略性地快速推进33款差异化且具有临床价值的资产管线,其中14款处于临床阶段,并已签署了九项对外许可协议,前期及里程碑付款合共高达118亿美元。截至2023年年报,科伦博泰生物-B营业总收入15.4亿元、净利润-5.74亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/13093440616540.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434886889","title":"港股异动 | 科伦博泰生物-B(06990)再涨超8%创新高 公司拟融资12亿 此前主要产品获FDA批准II期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2434886889","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434886889?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:29","pubTimestamp":1715326175,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科伦博泰生物-B再涨超8%,盘中高见192.8港元,创上市新高。科伦药业于公司的持股比例将保持在约54.8%。此外,科伦博泰生物本月初公布,主要产品A400获得美国食品药品监督管理局批准进入2期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119744.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434141079","title":"科伦博泰生物-B(06990)上涨5.01%,报186.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434141079","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434141079?lang=zh_cn&edition=full","pubTime":"2024-05-10 09:37","pubTimestamp":1715305067,"startTime":"0","endTime":"0","summary":"5月10日,科伦博泰生物-B盘中上涨5.01%,截至09:37,报186.4元/股,成交650.06万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司,主要致力于内部开发差异化的治疗方法,以支持提高现有的医疗健康水平。截至2023年年报,科伦博泰生物-B营业总收入15.4亿元、净利润-5.74亿元。5月8日,拟配售442.4万新股份,占扩大后股本1.99%,每股配售价150.00港元,较前一收市日折价6.83%(预案)。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/10093740593504.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434068569","title":"科伦博泰生物-B05月09日主力资金流入533万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2434068569","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434068569?lang=zh_cn&edition=full","pubTime":"2024-05-09 16:17","pubTimestamp":1715242621,"startTime":"0","endTime":"0","summary":"05月09日, 科伦博泰生物-B股价涨7.58%,报收177.50元,成交金额9394万元,换手率0.42%,振幅8.48%,量比1.03。科伦博泰生物-B今日主力资金净流入533万元,连续3日净流入,上一交易日主力净流入9016万元,今日环比减少94.09%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为77.78%,平均涨幅为2.62%。该股近5个交易日上涨5.66%,主力资金累计净流入9433万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入8672万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050916181487e3c5db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050916181487e3c5db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434363720","title":"港股异动 | 科伦博泰生物-B(06990)再涨超7% 公司拟再融资12亿 控股股东认购其中近7亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2434363720","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434363720?lang=zh_cn&edition=full","pubTime":"2024-05-09 11:08","pubTimestamp":1715224133,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科伦博泰生物-B早盘再度涨超7%,截至发稿,涨6.61%,报175.9港元,成交额2374.78万港元。消息面上,科伦博泰生物拟向不少于六名承配人配售364.86万股,每股作价150港元,较5月7日收盘价161港元折让约6.83%,所得款项净额约为5.405亿港元;公司另向控股股东科伦药业配售442.39万股,每股作价同为150港元,所得款项净额约为6.62亿港元。科伦药业于公司的持股比例将保持在约54.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119133.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433991711","title":"科伦博泰生物-B上榜05月08日主力资金加仓幅度前10个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2433991711","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433991711?lang=zh_cn&edition=full","pubTime":"2024-05-08 16:16","pubTimestamp":1715156172,"startTime":"0","endTime":"0","summary":"05月08日, 科伦博泰生物-B股价涨2.48%,报收165.00元,成交金额2.69亿元,换手率1.32%,振幅9.32%,量比7.33。科伦博泰生物-B今日主力资金净流入9016万元,上一交易日主力净流入19万元,今日环比增加47352.63%。该股近5个交易日下跌1.96%,主力资金累计净流入8946万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入6771万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050816165287df99e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050816165287df99e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433769842","title":"港股异动 | 科伦博泰生物-B(06990)现跌超4% 折价配股净筹超12亿港元 控股股东认购其中近7亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2433769842","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433769842?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:54","pubTimestamp":1715133259,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科伦博泰生物-B现跌超4%,截至发稿,跌3.35%,报155.6港元,成交额1.08亿港元。消息面上,科伦博泰生物拟向不少于六名承配人配售364.86万股,每股作价150港元,较上一日收盘价161元折让约6.83%,所得款项净额约为5.405亿港元;公司另向控股股东科伦药业配售442.39万股,每股作价同为150港元,所得款项净额约为6.62亿港元。科伦药业于公司的持股比例将保持在约54.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118582.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433376382","title":"【港股通】科伦博泰生物-B(06990)折让6.83%配股 净筹逾12亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433376382","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2433376382?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:15","pubTimestamp":1715130907,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科伦博泰生物-B 公布,公司与配售代理订立配售协议,拟配售364.86万股新H股予不少于6名承配人,占经发行配售股份及认购股份扩大后的公司已发行股本约1.61%。每股配售价为150.00港元,较上交易日收市价161港元折让6.83%。配售事项估计所得款项净额预期约为5.405亿港元,认购事项估计所得款项净额预期约为6.011亿元人民币。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/MzE0MDcxNDczNTEzNTE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzE0MDcxNDczNTEzNTE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936453","is_publish_highlight":false,"gpt_icon":0},{"id":"2433632757","title":"科伦博泰生物-B(06990.HK)折让6.8%配股 净筹逾12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433632757","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2433632757?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:15","pubTimestamp":1715130900,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B拟向不少于六名承配人配售364.86万股,占最终扩大股本约1.61%,每股作价150元,较上日收市价161元折让约6.83%,料净集资约5.41亿元。公司另向控股股东科伦药业配售442.39万股,占最终扩大股本约1.95%,每股作价同为150元,料净集资约6.62亿元。科伦药业于公司的持股比例将保持在约54.8%。(港股报价延迟最少十五分钟。沽空资料截至 2024-05-07 16:25。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1347995/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2433505997","title":"科伦博泰生物-B(06990)拟配售364.86万股配售股份及发行合共442.39万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433505997","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2433505997?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:32","pubTimestamp":1715128368,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990)发布公告,于2024年5月8日(交易时段前),公司与...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_45.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_45.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118553.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433768890","title":"科伦博泰生物-B(06990.HK)拟配售364.86万股配售股份及发行442.387万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433768890","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2433768890?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:25","pubTimestamp":1715127916,"startTime":"0","endTime":"0","summary":"2024年5月8日,公司与认购人订立认购协议,据此,认购人已有条件同意认购,且公司已有条件同意按认购价每股认购股份人民币136.21元配发及发行合共442.387万股认购股份。配售事项的估计所得款项净额预期约为5.405亿港元,认购事项的估计所得款项净额预期约为人民币6.011亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050808252487de1c89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050808252487de1c89&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433414071","title":"科伦博泰生物-B一度涨超11%创新高 主要产品获FDA批准2期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2433414071","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2433414071?lang=zh_cn&edition=full","pubTime":"2024-05-06 15:34","pubTimestamp":1714980883,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(6990.HK)午后一度涨超11%,高见182.2港元刷新上市高价,总市值近400亿港元。该公司的主要产品A400(EP0031)(在转染过程中重排(RET)小分子激酶抑制剂项目,亦称为KL590586或EP0031)获得了美国食品药品监督管理局(FDA)批准进入2期临床开发。A400(EP0031)是第二代选择性RET抑制剂(SRI),对常见的RET基因融合和突变具有广泛活性。\n\n\r\n 责任编辑:山上","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/06153440528022.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":-0.0968},{"period":"1month","weight":0.2237},{"period":"3month","weight":0.7781},{"period":"6month","weight":0.8988},{"period":"1year","weight":1.8168},{"period":"ytd","weight":0.6589}],"compareEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.2032},{"period":"3month","weight":0.1967},{"period":"6month","weight":0.1203},{"period":"1year","weight":-0.0088},{"period":"ytd","weight":0.147}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。该公司主要从事生物药品、化学药品原料、化学药品制剂的研发、生产和销售。该公司的产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。","exchange":"SEHK","name":"科伦博泰生物-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦博泰生物-B,06990,科伦博泰生物-B股票,科伦博泰生物-B股票老虎,科伦博泰生物-B股票老虎国际,科伦博泰生物-B行情,科伦博泰生物-B股票行情,科伦博泰生物-B股价,科伦博泰生物-B股市,科伦博泰生物-B股票价格,科伦博泰生物-B股票交易,科伦博泰生物-B股票购买,科伦博泰生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}